Ltr Pharma Fpo has released a press release.
LTR Pharma completes A$10.5 million placement
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from LTR Pharma
- SPONTAN achieves positive clinical study results
- Reinstatement to quotation
- Suspension from Quotation
- Response to ASX Price Query
- Final Patients dosed in SPONTAN pivotal study
Later from LTR Pharma
- SPONTAN prescribed to First Patient Under TGA
- Mens Health Expert Prescribes SPONTAN
- LTP Secures Global CoDevelopment Agreement with Aptar Pharma
- SPONTAN Prescribed to First Patient by Authorised Prescriber
- Appendix 4E and Annual Financial Report
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma